Skip to main content

Market Overview

Akebia Therapeutics (NASDAQ: AKBA)

3.68 +0.01 (0.27%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2022
Pre-Market
EPS:
REV:




Q4 2021
Pre-Market
EPS:
REV:




Q3 2021
Pre-Market
EPS:
REV:
-0.42
59.988M



Q2 2021
Pre-Market
EPS:
REV:




Q1 2021
Pre-Market
EPS:
REV:
-0.47
88.478M
-0.36
42.84M
-0.45
52.304M
-25%
22.09%
Q4 2020
Pre-Market
EPS:
REV:
-0.79
69.555M
-0.40
51.16M
-0.60
56.699M
-50%
10.83%
Q3 2020
Pre-Market
EPS:
REV:
-0.46
91.977M
-0.17
84.9M
-0.42
59.988M
-147.06%
-29.34%
Q2 2020
Pre-Market
EPS:
REV:
-0.25
100.803M
-0.50
74.18M
-0.44
90.142M
12%
21.52%
Q1 2020
Pre-Market
EPS:
REV:
-0.44
72.666M
-0.62
77.48M
-0.47
88.478M
24.19%
14.19%
Q4 2019
Pre-Market
EPS:
REV:
-0.76
59.85M
-0.47
93.15M
-0.79
69.555M
-68.09%
-25.33%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!